Dallas

2018 Annual Conference

The IHFDA 2018 conference turned out to be a huge success. Attendees were able to listen to some of the true experts in the field of health facility diversion present some of the most pressing issues currently being faced by our members.  In addition, networking with other professionals in their field, along with a strong exhibitor field made for a formable conference for all. Positive comments were abundant as the IHFDA board also listened to how we can make a great conference even better in 2019 in Orlando.

Thanks to all who attended in 2018, hope to see all of you in Orlando in 2019.

John Burke
IHFDA President

Kim New
Executive Director
 

CE credit information is below.

Conference Agenda

Conference Speakers (A-Z)

Jeff Andert

Jeff Andert

Compliance Consultant
Kaiser Permanente
Enterprise Regional Compliance, Care Delivery and Pharmacy

“Pharmacy Investigations at Kaiser Permanente”

SPEAKER BIO

Harry Heinonen

Harry Heinonen

Compliance Consultant
Kaiser Permanente
Enterprise Regional Compliance, Care Delivery and Pharmacy

“Pharmacy Investigations at Kaiser Permanente”

SPEAKER BIO

 

Karen Lettre

Karen Lettre

Diversion Specialist, Texas Children’s Hospital

“Developing a Diversion Prevention Program in a Children’s Health System”

SPEAKER BIO

Dennis Luken

Dennis Luken

Treasurer, IHFDA

 “Understanding the Law Enforcement Perspective on Diversion”

SPEAKER BIO

Lauren Lollini

Lauren Lollini

Secretary, IHFDA

“A Victim’s Perspective”

SPEAKER BIO

Jeannell M. Mansur, R.Ph, Pharm.D, FASHP, FSMSO, CJCP

Jeannell M. Mansur, R.Ph, Pharm.D, FASHP, FSMSO, CJCP

Principal Consultant, Medication Management and Safety
Joint Commission Resources/Joint Commission International

“Medication Management and Diversion”

SPEAKER BIO

Jason Mehr, MPH, CIC

Jason Mehr, MPH, CIC

Healthcare Associated Infections Coordinator
Communicable Disease Service
New Jersey Department of Health

“Collaboration Between Public Health and Healthcare Facilities”

Ben Mink

Ben Mink

President and CEO, GTC Consulting Inc.

“A Close Encounter: How to Effectively Reduce Controlled Substance Liability- Pre, Mid, & Post DEA Regulatory Action”

SPEAKER BIO

Philip A. Mullenix

Philip A. Mullenix

John E. Reid and Associates

“The Reid Technique of Investigative Interviewing”

SPEAKER BIO

Aurora Pop-Vicas, MD, MPH

Aurora Pop-Vicas, MD, MPH

Assistant Professor, Infectious Diseases, Associate Hospital Epidemiologist, University of Wisconsin School of Medicine

“Tampering and Substitution: A Case Study from the University of Wisconsin”

Shabbir Imber Safdar

Shabbir Imber Safdar

Executive Director
Partnership of Safe Medicines

“Protecting Patients from Harm Associated with Counterfeit Medications”

SPEAKER BIO

Shawn Parekh, PharmD, MHA, FACHE

Shawn Parekh, PharmD, MHA, FACHE

National, Chief Pharmacy Officer

Prospect Medical Holdings, Inc

“A Case Study on Diversion, A Culture of Excellence”

SPEAKER BIO

Michele Sheaffer

Michele Sheaffer

Assistant Director of Pharmacy

Abington Memorial Hospital

“A Case Study on Diversion, A Culture of Excellence”

SPEAKER BIO

Greg Raymond DNP, MBA, RN, NEA-BC

Greg Raymond DNP, MBA, RN, NEA-BC

Vice President of Nursing, University of Maryland Medical Center

“Using Huddles to Improve Diversion Investigations”

SPEAKER BIO

Lisa Robin, MLA

Lisa Robin, MLA

Chief Advocacy Officer at Federation of State Medical Boards

“Role of Medical Boards in Drug Diversion Cases”

SPEAKER BIO

Dr. Lynn Webster, M.D.

Dr. Lynn Webster, M.D.

“Patient Care in the New Normal-One Physician’s Experience”

SPEAKER BIO

CE Credit Information

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety.  Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Nurses / Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Internal Health Facility Diversion Association.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 14.25 contact hours for nurses and number of knowledge/application/practice-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Exhibitors (A-Z)